基于脂质的黄素纳米输送系统:最近的进展,方法和应用
Asli Can Karaca1, Atefe Rezaei2, Muhammad Qamar3
1Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, 34469 Istanbul, Turkey.
Food chemistry
|September 14, 2024
概括
基于脂质的纳米载体 (LBNs) 增强了黄素.
科学领域:
- 制药纳米技术 制药纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 黄素 (CUR) 具有有益的效果,但由于化学不稳定性,溶解性低,生物可用性弱,因此药物应用不佳.
- 纳米技术为CUR传递提供解决方案,目前正在广泛研究基于脂质的纳米载体 (LBNs).
研究的目的:
- 审查CUR装载LBN的最新进展.
- 讨论改善CUR生物可用性和释放特性的方法.
- 介绍CUR装载LBN的挑战和潜在应用.
主要方法:
- 对CUR装载LBN的最新科学文献的审查.
- 对影响LBN特征的配方和加工参数的分析.
- 讨论提高CUR生物利用率和释放的方法.
主要成果:
- 包括纳米乳液和固体脂质载体在内的LBN显示出改善CUR可溶性,生物可用性和稳定性的前景.
- 可以优化CUR载荷LBN的颗粒特性,稳定性,生物可用性和释放概况.
- 存在各种策略来增强CUR生物可用性和从LBNs释放.
结论:
- 装有CUR的LBN是有效的交付系统,可以解决CUR的局限性.
- 优化配方和加工是定制LBN性能的关键.
- 需要进一步研究CUR装载LBN的挑战和应用.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.


